Related Experiment Video
Updated: Nov 16, 2025
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
TB control in India in the COVID era
1Dept. of Pulmonary Medicine, WHO Collaborating Centre for Research & Capacity Building in Chronic Respiratory Diseases, Postgraduate Institute of Medical Education & Research, Chandigarh, 160012, India; National Task Force (NTEP/RNTCP).
The COVID-19 pandemic disrupted India's National Tuberculosis Elimination Program (NTEP), impacting TB control efforts. Strategies are needed to overcome challenges and achieve the End TB by 2025 goal.
Area of Science:
- Public Health
- Infectious Disease Control
- Epidemiology
Background:
- The COVID-19 pandemic significantly disrupted global healthcare delivery.
- Public health programs, including tuberculosis (TB) control, faced unprecedented challenges worldwide.
- India's National Tuberculosis Elimination Program (NTEP) was particularly affected.
Purpose of the Study:
- To analyze the impact of the COVID-19 pandemic on TB control in India.
- To identify the specific challenges faced by the NTEP.
- To discuss potential strategies for overcoming these difficulties and resuming progress towards TB elimination.
Main Methods:
- Review of the impact of pandemic-related disruptions on NTEP operations.
- Analysis of factors affecting TB case notification and program activities.
- Discussion of adaptive strategies implemented or proposed for TB control during the pandemic.
Main Results:
- Lockdowns, fear of infection, redeployment of healthcare workers, and diversion of resources hampered TB control.
- Diagnostic facilities and hospital services were repurposed, affecting TB case detection and management.
- Progress towards the End TB by 2025 target has been adversely affected.
Conclusions:
- The COVID-19 pandemic posed significant obstacles to TB control in India.
- Addressing these challenges requires innovative strategies and sustained focus on TB elimination.
- Overcoming pandemic-induced setbacks is crucial to achieving the End TB by 2025 goal.
More Related Videos
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
Related Concept Videos
01:28Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
01:29Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:28Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:31Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
01:26Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:25Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...